These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 16430457

  • 1. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B, Aktan M, Sami U, Oner D, Sanem O, Dinçol G.
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [Abstract] [Full Text] [Related]

  • 2. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.
    Haematologica; 1996 Feb; 81(5):428-33. PubMed ID: 8952156
    [Abstract] [Full Text] [Related]

  • 3. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
    Meuleman N, Stamatopoulos B, Dejeneffe M, El Housni H, Lagneaux L, Bron D.
    Leukemia; 2008 Oct; 22(10):1882-90. PubMed ID: 18633433
    [Abstract] [Full Text] [Related]

  • 4. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
    Rivkina A, Vitols G, Murovska M, Lejniece S.
    Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia.
    Del Principe MI, Del Poeta G, Venditti A, Buccisano F, Maurillo L, Marini R, Cox MC, Panetta P, Suppo G, Degan M, Bruno A, Gattei V, Amadori S.
    Haematologica; 2004 Dec; 89(12):1468-75. PubMed ID: 15590397
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
    Callea V, Morabito F, Luise F, Piromalli A, Filangeri M, Stelitano C, Iacopino P, Nobile F, Brugiatelli M.
    Haematologica; 1996 Dec; 81(4):310-5. PubMed ID: 8870374
    [Abstract] [Full Text] [Related]

  • 8. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y, Lampertz S, De Groote D, Igot D, Malaise M, Fillet G.
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [Abstract] [Full Text] [Related]

  • 9. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W, Willheim M, Hilgarth M, Gasché C, Mader R, Szepfalusi S, Steger G, Berger R, Lechner K, Boltz-Nitulescu G.
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [Abstract] [Full Text] [Related]

  • 10. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
    Molica S, Digiesi G, Battaglia C, Cutrona G, Antenucci A, Molica M, Giannarelli D, Sperduti I, Gentile M, Morabito F, Ferrarini M.
    Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
    [Abstract] [Full Text] [Related]

  • 11. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia.
    Musolino C, Allegra A, Alonci A, Saija A, Russo S, Cannavò A, Cristani M, Centorrino R, Saitta S, Alibrandi A, Gangemi S.
    Clin Biochem; 2011 Dec; 44(17-18):1487-90. PubMed ID: 21945028
    [Abstract] [Full Text] [Related]

  • 12. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R, Ambrosetti A, Lestani M, Ghia P, Pattaro C, Remo A, Zanetti F, Stella S, Perbellini O, Prato G, Guida G, Caligaris-Cappio F, Menestrina F, Pizzolo G, Chilosi M.
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
    Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D.
    Blood; 1996 Dec 01; 88(11):4259-64. PubMed ID: 8943862
    [Abstract] [Full Text] [Related]

  • 17. Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen.
    Bojarska-Junak A, Hus I, Szczepanek EW, Dmoszyńska A, Roliński J.
    Leuk Res; 2008 Feb 01; 32(2):225-33. PubMed ID: 17675228
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.
    Nückel H, Collins CH, Frey UH, Sellmann L, Dürig J, Siffert W, Dührsen U.
    Eur J Haematol; 2009 Dec 01; 83(6):541-9. PubMed ID: 19682311
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L.
    Am J Hematol; 2007 Sep 01; 82(9):787-91. PubMed ID: 17534928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.